
Moshe Prero, MD, says gene therapy has changed respiratory care in SMA type 1, but residual sleep, swallowing, and spinal issues still warrant monitoring.

Moshe Prero, MD, pediatric pulmonologist and sleep medicine physician at University Hospitals (UH) Rainbow Babies and Children’s Hospital.